How to mitigate neurological and cardiac decompensation in Leigh syndrome: Can nicotinamide riboside be an answer?
Main Authors: | Alessandro Prigione, Carlo Viscomi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | Clinical and Translational Discovery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctd2.124 |
Similar Items
-
Synthesis, Stability, and Bioavailability of Nicotinamide Riboside Trioleate Chloride
by: Amin Zarei, et al.
Published: (2021-12-01) -
Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice
by: Patrick M. Schaefer, et al.
Published: (2022-10-01) -
Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD<sup>+</sup> by Generating Dihydronicotinamide Riboside
by: Eleonora Ciarlo, et al.
Published: (2022-07-01) -
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
by: Rachel S. Fletcher, et al.
Published: (2017-08-01) -
Enzymatic synthesis of high-titer nicotinamide mononucleotide with a new nicotinamide riboside kinase and an efficient ATP regeneration system
by: Xiao-Long Qian, et al.
Published: (2022-03-01)